Pharma Journalist -

Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in…
Read More...

Johnson & Johnson announced that the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of the Company’s…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced a new supply agreement with Israel for 2022. Under the terms of this…
Read More...

Janux Therapeutics announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford…
Read More...

Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome. As Adare has committed to growing its Pharma Solutions and…
Read More...

Syneos Health the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform for patient-centered drug development, announced a strategic…
Read More...

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced…
Read More...

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership with Rocket Pharmaceuticals, a…
Read More...

Today, the European Commission (EC) approved Sarclisa (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with relapsed multiple…
Read More...

Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, announced a strategic partnership to accelerate the…
Read More...